This page includes the latest FDA filings for Emergent Biosolutions Canada Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
|---|---|---|
| Emergent BIoSolutions Canada Inc. | Other Medication | 2021-06-22 |
| Emergent BIoSolutions Canada Inc. | Other Medication | 2020-01-14 |
| Emergent BIoSolutions Canada Inc. | Other Medication | 2019-12-11 |
| Emergent BIoSolutions Canada Inc. | Other Medication | 2019-10-05 |
| Emergent BioSolutions Canada Inc. | Prescription Medication | 2019-05-22 |
| Cangene BioPharma, Emergent Biosolutions Canada Inc | Other Medication | 2019-02-08 |
| Emergent BioSolutions Canada Inc. | Other Medication | 2018-12-01 |
| Emergent BioSolutions Canada Inc. | Anthrasil | 2015-10-05 |
| Emergent BIoSolutions Canada Inc. | BAT | 2013-03-01 |
| Emergent BioSolutions Canada Inc. | CNJ-016 | 2005-05-01 |
| NCAGE Code | L0EM2 | EMERGENT BIOSOLUTIONS CANADA INC |
| CAGE Code | L0EM2 | EMERGENT BIOSOLUTIONS CANADA INC |
| S.A.M. Registration | L0EM2 [203508049] | EMERGENT BIOSOLUTIONS CANADA INC |